Clinical Trials Browser

Phase 1 × INDUSTRY × lumiliximab × Clear all

NCT00046488 2013-09-16

Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell